Why the study?
Do the lysine binding regions of Lipoprotein (a) mediate its reduction of collagen-stimulated platelet aggregation in vitro?
Do the lysine binding regions of Lipoprotein (a) mediate its reduction of collagen-stimulated platelet aggregation in vitro?
The reduction of collagen-stimulated platelet aggregation by intact Lipoprotein (a) in vitro is not mediated by its lysine-binding regions.
Lysine-binding regions do not mediate Lp(a) effects on platelet aggregation in vitro; leaves open alternative mechanisms and in vivo relevance.
Intact lipoprotein (a) (Lp (a)) is known to decrease collagen-stimulated platelet aggregation in vitro, though the nature of the interaction between this lipoprotein and stimulated platelets is unknown. Lysine binding regions of Lp (a) facilitate binding between it and at least one cell type. Epsilon aminocaproic acid (EACA) renders Lp (a)'s lysine binding regions incapable of cellular interaction using those regions. Washed human platelets were presented vehicle alone or with varying concentrations of Lp (a) either not exposed or previously exposed to increasing levels of EACA. In all experiments, EACA failed to affect the impact of Lp(a) on platelet aggregation. It is concluded that the lysine binding regions of Lp (a) do not mediate the intact Lp(a)-induced reduction of collagen-stimulated platelet aggregation in vitro.
No takes yet. Share an insight, caveat, or question.
Douglas E. Barre (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: